A curated digest of the latest longevity and healthy-ageing research and news, updated weekly. Headlines and a short read, with a link to the original source.
A mouse study examined blocking the growth hormone receptor and reported modest aging effects.
Why it mattersAdds evidence on endocrine pathways in aging biology, though mouse results often do not translate to humans.
Research examines RUNX2 inhibition as a possible strategy in osteoporosis.
Why it mattersBone loss matters for aging, but clinical relevance and safety require human data.
The September 14, 2026 edition gathers recent aging research links and commentary.
Why it mattersUseful for tracking developments and debates across the longevity field in one place.
Study describes how dendritic cells help T cells access the brain and influence tau pathology.
Why it mattersClarifies immune mechanisms in neurodegenerative disease, a key area for aging brain research.
A lung fibrosis drug was linked to lower biological age estimates in a study.
Why it mattersRaises questions about whether such markers reflect aging biology or disease specific effects.
A gene therapy from Genflow reduced biological age markers in older dogs.
Why it mattersCompanion animal data may inform translation, but species differences and controls matter for interpretation.
FDA cleared a C2N Diagnostics blood test intended to aid early Alzheimer's detection.
Why it mattersBlood based testing could change diagnosis pathways and research enrollment if validated in practice.
A model described as SCI extends longevity work beyond clinical settings.
Why it mattersHighlights efforts to connect clinical longevity interventions with broader public health and policy.
The week's longevity news, curated, once a week. No noise.